InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Gilley Thomas, Director. Director active across 1 company, notably BIO KEY International INC. Aggregated, 8 filings have been published. Activity tracked since 12 August 2021. The latest transaction was disclosed on 10 November 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
8 of 8 declarations
Thomas Gilley is a Director at BIO KEY INTERNATIONAL INC. As a board member, he contributes to the governance of the company and strategic decision-making. His expertise in the biotechnology sector helps BIO KEY develop innovative solutions.